Advertisement

Adiponectin/SIRT1 Axis Induces White Adipose Browning After Vertical Sleeve Gastrectomy of Obese Rats with Type 2 Diabetes

  • Lei Liu
  • Tianyi Zhang
  • Jingyao Hu
  • Rui Ma
  • Bing He
  • Mofei Wang
  • Yong WangEmail author
Original Contributions
  • 79 Downloads

Abstract

Purpose

White adipose tissue (WAT) browning plays a crucial role in energy metabolism. However, it remains unclear whether WAT browning is involved in the adipose reduction following sleeve gastrectomy (SG). Adiponectin is upregulated after Roux-en-Y gastric bypass surgery. The role of adiponectin in SG was further investigated in the current study.

Materials and Methods

Diabetic Sprague Dawley rats were randomly divided into control, sham + libitum, sham + food restriction, and sleeve groups. Browning markers, including uncoupling protein 1 (UCP1), peroxisome proliferator-activated receptor (PPAR) γ, and PPARγ coactivator-1 alpha (PGC-1α), were examined 4 weeks after the operation.

Results

UCP1, PPARγ, and PGC-1α expression were significantly higher in the sleeve group compared to the other study groups. The adipose tissue of the sleeve group exhibited tissue weight loss and additional morphological browning features. In addition, adiponectin expression in the sleeve group was significantly increased. Adiponectin upregulated the expression of the browning genes and sirtuin 1 (SIRT1) in 3T3-L1 adipocytes. SIRT1 could increase the WAT browning levels, revealing that adiponectin induced the browning process via the upregulation of SIRT1. Furthermore, SIRT1 represented a positive regulatory feedback loop for adiponectin. SIRT1 activated adenosine monophosphate-activated protein kinase (AMPK), which can mediate WAT browning. Inhibition of the AMPK signaling pathway by dorsomorphin decreased UCP1, PPARγ, and PGC-1α expression. However, additional studies are needed to understand the relationship between adiponectin and glucose homeostasis.

Conclusions

Sleeve gastrectomy increased adiponectin levels, which in turn upregulated SIRT1. Thus, SIRT1 may function as an endocrine signal to mediate WAT browning.

Keywords

Sleeve gastrectomy Adiponectin SIRT1 White adipose tissue Beige adipose tissue 

Notes

Author Contribution

Lei Liu:Models construction and samples obtaining and manuscript writing

Tianyi Zhang:Cell culture and transfection

Jingyao Hu:Western blot

Rui Ma:PCR

Bing He:Immunohistocheistry staining

Mofei Wang:Data Statistics

Yong Wang:Responsible for study design

Funding Information

This study was funded by the National Natural Science Foundation of China (No. 81702402, No. 81570765, No. 81802760) and Science and Technology Project of Liaoning (No. 20170520027, No. 201602866, No. 2015020539).

Compliance with Ethical Standards

Ethical Approval and Animal Welfare

The study was approved by an animal care committee of Shengjing Hospital. The welfare of animals used for research was respected. All applicable institutional and/or national guidelines for the care and use of animals were followed. This article does not contain any studies with human participants, and informed consent is not required.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, et al. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention. CA Cancer J Clin. 2017;67(5):378–97.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016;12(1):15–28.PubMedCrossRefGoogle Scholar
  3. 3.
    Jia G, Jia Y, Sowers JR. Contribution of maladaptive adipose tissue expansion to development of cardiovascular disease. Compr Physiol. 2016;7(1):253–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Giles ED, Wellberg EA, Astling DP, et al. Obesity and overfeeding affecting both tumor and systemic metabolism activates the progesterone receptor to contribute to postmenopausal breast cancer. Cancer Res. 2012;72(24):6490–501.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Bray GA, Fruhbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387(10031):1947–56.PubMedCrossRefGoogle Scholar
  6. 6.
    Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.PubMedCrossRefGoogle Scholar
  8. 8.
    He B, Chen L, Yu C, et al. Roux-en-Y gastric bypass increases hepatic and peripheral insulin sensitivity in rats with type 2 diabetes mellitus. Surg Obes Relat Dis. 2014;10(3):485–93.PubMedCrossRefGoogle Scholar
  9. 9.
    Bojsen-Moller KN, Dirksen C, Jorgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes. 2014;63(5):1725–37.PubMedCrossRefGoogle Scholar
  10. 10.
    He B, Piao D, Yu C, et al. Amelioration in hepatic insulin sensitivity by reduced hepatic lipid accumulation at short-term after Roux-en-Y gastric bypass surgery in type 2 diabetic rats. Obes Surg. 2013;23(12):2033–41.PubMedCrossRefGoogle Scholar
  11. 11.
    Douros JD, Niu J, Sdao S, et al. Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control. Mol Metab. 2019;28:144–50.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Fruhbeck G, Diez Caballero A, Gil MJ. Fundus functionality and ghrelin concentrations after bariatric surgery. N Engl J Med. 2004;350(3):308–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Gribble FM, Reimann F. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol. 2019;15(4):226–37.PubMedCrossRefGoogle Scholar
  14. 14.
    Lutz TA, Osto E. Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism. Curr Opin Lipidol. 2016;27(3):257–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Patel A, Yusta B, Matthews D, et al. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr(-/-) mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy. Mol Metab. 2018;16:45–54.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Stefater MA, Wilson-Perez HE, Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Culnan DM, Cooney RN, Stanley B, et al. Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass. Obesity (Silver Spring). 2009;17(1):46–52.CrossRefGoogle Scholar
  18. 18.
    Dodd GT, Decherf S, Loh K, et al. Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell. 2015;160(1-2):88–104.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847–53.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Wu J, Cohen P, Spiegelman BM. Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 2013;27(3):234–50.PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Nedergaard J, Cannon B. The browning of white adipose tissue: some burning issues. Cell Metab. 2014;20(3):396–407.PubMedCrossRefGoogle Scholar
  22. 22.
    Chai F, Wang Y, Zhou Y, et al. Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery. Obes Surg. 2011;21(6):768–73.PubMedCrossRefGoogle Scholar
  23. 23.
    Gillum MP, Erion DM, Shulman GI. Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med. 2011;17(1):8–13.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Price NL, Gomes AP, Ling AJ, et al. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15(5):675–90.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Lee JH, Koh H, Kim M, et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature. 2007;447(7147):1017–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Ahmadian M, Abbott MJ, Tang T, et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 2011;13(6):739–48.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Barroso E, Rodriguez-Calvo R, Serrano-Marco L, et al. The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation. Endocrinology. 2011;152(5):1848–59.PubMedCrossRefGoogle Scholar
  29. 29.
    Hoffmann JM, Grunberg JR, Church C, et al. BMP4 gene therapy in mature mice reduces BAT activation but protects from obesity by browning subcutaneous adipose tissue. Cell Rep. 2017;20(5):1038–49.PubMedCrossRefGoogle Scholar
  30. 30.
    Qiang L, Wang L, Kon N, et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell. 2012;150(3):620–32.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Tiraby C, Tavernier G, Lefort C, et al. Acquirement of brown fat cell features by human white adipocytes. J Biol Chem. 2003 Aug 29;278(35):33370–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Bruinsma BG, Uygun K, Yarmush ML, et al. Surgical models of Roux-en-Y gastric bypass surgery and sleeve gastrectomy in rats and mice. Nat Protoc. 2015;10(3):495–507.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Wang Y, Liu J. Sleeve gastrectomy relieves steatohepatitis in high-fat-diet-induced obese rats. Obes Surg. 2009;19(7):921–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Schauer PR, Bhatt DL, Kashyap SR. Bariatric surgery or intensive medical therapy for diabetes after 5 years. N Engl J Med. 2017;376(20):1997.PubMedGoogle Scholar
  35. 35.
    Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84(1):277–359.PubMedCrossRefGoogle Scholar
  36. 36.
    Bartelt A, Heeren J. Adipose tissue browning and metabolic health. Nat Rev Endocrinol. 2014;10(1):24–36.PubMedCrossRefGoogle Scholar
  37. 37.
    Moncada R, Becerril S, Rodriguez A, et al. Sleeve gastrectomy reduces body weight and improves metabolic profile also in obesity-prone rats. Obes Surg. 2016;26(7):1537–48.PubMedCrossRefGoogle Scholar
  38. 38.
    Yong W, Shibo W, Jingang L. Remission of insulin resistance in type 2 diabetic patients after gastric bypass surgery or exenatide therapy. Obes Surg. 2012;22(7):1060–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Yang J, Feng X, Zhong S, et al. Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI >/= 32.5 kg/m(2.). Obes Surg. 2014;24(4):561–71.PubMedCrossRefGoogle Scholar
  40. 40.
    Hankir MK, Seyfried F, Hintschich CA, et al. Gastric bypass surgery recruits a gut PPAR-alpha-striatal D1R pathway to reduce fat appetite in obese rats. Cell Metab. 2017;25(2):335–44.PubMedCrossRefGoogle Scholar
  41. 41.
    Dockray GJ, Varro A, Dimaline R. Gastric endocrine cells: gene expression, processing, and targeting of active products. Physiol Rev. 1996;76(3):767–98.PubMedCrossRefGoogle Scholar
  42. 42.
    Rees WD, Garner A, Turnberg LA. Studies of acid and alkaline secretion by rabbit gastric fundus in vitro: effect of low concentrations of sodium taurocholate. Gastroenterology. 1982;83(2):435–40.PubMedGoogle Scholar
  43. 43.
    Lirun K, Sewe M, Yong W. A Pilot Study: The effect of Roux-en-Y gastric bypass on the serum microRNAs of the type 2 diabetes patient. Obes Surg. 2015;25(12):2386–92.PubMedCrossRefGoogle Scholar
  44. 44.
    Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21(3):369–78.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Stefanidis A, Oldfield BJ. Neuroendocrine mechanisms underlying bariatric surgery: Insights from human studies and animal models. J Neuroendocrinol. 2017;29(10)CrossRefGoogle Scholar
  46. 46.
    Zhang D, Wang X, Wang B, et al. Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors. Mol Psychiatry. 2017;22(7):1044–55.PubMedCrossRefGoogle Scholar
  47. 47.
    Palmer BF, Clegg DJ. Non-shivering thermogenesis as a mechanism to facilitate sustainable weight loss. Obes Rev. 2017;18(8):819–31.PubMedCrossRefGoogle Scholar
  48. 48.
    Wang L, Teng R, Di L, et al. PPARalpha and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders. Diabetes. 2013;62(12):4122–31.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Xu F, Zheng X, Lin B, et al. Diet-induced obesity and insulin resistance are associated with brown fat degeneration in SIRT1-deficient mice. Obesity (Silver Spring). 2016;24(3):634–42.CrossRefGoogle Scholar
  50. 50.
    Shan T, Liang X, Bi P, et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J. 2013;27(5):1981–9.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Kim N, Nam M, Kang MS, et al. Piperine regulates UCP1 through the AMPK pathway by generating intracellular lactate production in muscle cells. Sci Rep. 2017;7:41066.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Okazaki M, Iwasaki Y, Nishiyama M, et al. PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr J. 2010;57(5):403–13.PubMedCrossRefGoogle Scholar
  53. 53.
    Yang Y, Bai T, Yao YL, et al. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury. Toxicol Lett. 2016;262:80–91.PubMedCrossRefGoogle Scholar
  54. 54.
    Xue Y, Xu X, Zhang XQ, et al. Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles. Proc Natl Acad Sci U S A. 2016;113(20):5552–7.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of General SurgeryShengjing Hospital of China Medical UniversityShenyangPeople’s Republic of China
  2. 2.Department of General SurgeryThe Forth Hospital of China Medical UniversityShenyangPeople’s Republic of China
  3. 3.Department of EndocrinologyShengjing Hospital of China Medical UniversityShenyangPeople’s Republic of China

Personalised recommendations